{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:31:50Z","timestamp":1788834710594,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T00:00:00Z","timestamp":1526860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the foundation for cardiac surgery"},{"name":"the Saucez-Van Pouke Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12872-018-0831-3","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T07:34:33Z","timestamp":1526888073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of the cardiac myosin activator Omecamtiv-mecarbil on severe chronic aortic regurgitation in Wistar rats"],"prefix":"10.1186","volume":"18","author":[{"given":"Bachar","family":"El-Oumeiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Mc Entee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Annoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Herpain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Vanden Eynden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Jespers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Van Nooten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"van de Borne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,21]]},"reference":[{"issue":"7","key":"831_CR1","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1136\/hrt.2004.042614","volume":"92","author":"G Maurer","year":"2006","unstructured":"Maurer G. Aortic regurgitation. Heart. 2006 Jul;92(7):994\u20131000.","journal-title":"Heart"},{"issue":"14","key":"831_CR2","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1161\/01.CIR.99.14.1851","volume":"99","author":"KS Dujardin","year":"1999","unstructured":"Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, Seward JB, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation. 1999 Apr 13;99(14):1851\u20137.","journal-title":"Circulation"},{"issue":"5","key":"831_CR3","first-page":"573","volume":"12","author":"A Chockalingam","year":"2003","unstructured":"Chockalingam A, Gnanavelu G, Elangovan S, Chockalingam V. Current profile of acute rheumatic fever and valvulitis in southern India. J Heart Valve Dis. 2003 Sep;12(5):573\u20136.","journal-title":"J Heart Valve Dis"},{"issue":"3","key":"831_CR4","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1161\/01.CIR.82.3.1051","volume":"82","author":"BA Carabello","year":"1990","unstructured":"Carabello BA. Aortic regurgitation. A lesion with similarities to both aortic stenosis and mitral regurgitation. Circulation. 1990 Sep;82(3):1051\u20133.","journal-title":"Circulation"},{"issue":"2","key":"831_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11936-000-0005-2","volume":"2","author":"RO Bonow","year":"2000","unstructured":"Bonow RO. Aortic Regurgitation. Curr Treat Options Cardiovasc Med. 2000 Apr;2(2):125\u201332.","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"13","key":"831_CR6","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1056\/NEJMoa050666","volume":"353","author":"A Evangelista","year":"2005","unstructured":"Evangelista A, Tornos P, Sambola A, Permanyer-Miralda G, Soler-Soler J. Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med. 2005 Sep 29;353(13):1342\u20139.","journal-title":"N Engl J Med"},{"issue":"4","key":"831_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ahj.2007.01.006","volume":"153","author":"A Mahajerin","year":"2007","unstructured":"Mahajerin A, Gurm HS, Tsai TT, Chan PS, Nallamothu BK. Vasodilator therapy in patients with aortic insufficiency: a systematic review. Am Heart J. 2007 Apr;153(4):454\u201361.","journal-title":"Am Heart J"},{"issue":"2 Pt 2","key":"831_CR8","first-page":"H556","volume":"267","author":"NM Magid","year":"1994","unstructured":"Magid NM, Opio G, Wallerson DC, Young MS, Borer JS. Heart failure due to chronic experimental aortic regurgitation. Am J Physiol. 1994 Aug;267(2 Pt 2):H556\u201362.","journal-title":"Am J Physiol"},{"issue":"2","key":"831_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1054\/jcaf.2003.17","volume":"9","author":"E Plante","year":"2003","unstructured":"Plante E, Couet J, Gaudreau M, Dumas MP, Drolet MC, Arsenault M. Left ventricular response to sustained volume overload from chronic aortic valve regurgitation in rats. J Card Fail. 2003 Apr;9(2):128\u201340.","journal-title":"J Card Fail"},{"key":"831_CR10","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1161\/01.CIR.97.6.525","volume":"97","author":"JS Borer","year":"1998","unstructured":"Borer JS, Hochreiter C, Herrold EM, et al. Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. Circulation. 1998;97:525\u201334.","journal-title":"Circulation"},{"issue":"5","key":"831_CR11","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0735-1097(87)80362-5","volume":"10","author":"KM Borow","year":"1987","unstructured":"Borow KM. Surgical outcome in chronic aortic regurgitation: a physiologic framework for assessing preoperative predictors. J Am Coll Cardiol. 1987 Nov;10(5):1165\u201370.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"831_CR12","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","volume":"83","author":"KT Weber","year":"1991","unstructured":"Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991 Jun;83(6):1849\u201365.","journal-title":"Circulation"},{"issue":"9792","key":"831_CR13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0140-6736(11)61038-6","volume":"378","author":"H Krum","year":"2011","unstructured":"Krum H, Teerlink JR. Medical therapy for chronic heart failure. Lancet. 2011 Aug 20;378(9792):713\u201321.","journal-title":"Lancet"},{"key":"831_CR14","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/164_2017_13","volume":"243","author":"MA Psotka","year":"2017","unstructured":"Psotka MA, Teerlink JR. Direct myosin activation by Omecamtiv Mecarbil for heart failure with reduced ejection fraction. Handb Exp Pharmacol. 2017;243:465\u201390.","journal-title":"Handb Exp Pharmacol"},{"issue":"4","key":"831_CR15","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/CIRCHEARTFAILURE.109.930321","volume":"3","author":"YT Shen","year":"2010","unstructured":"Shen YT, Malik FI, Zhao X, Depre C, Dhar SK, Abarz\u00faa P, Morgans DJ, Vatner SF. Improvement of cardiac function by a cardiac myosin activator in conscious dogs with systolic heart failure. Circ Heart Fail. 2010 Jul;3(4):522\u20137.","journal-title":"Circ Heart Fail."},{"issue":"6023","key":"831_CR16","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1126\/science.1200113","volume":"331","author":"FI Malik","year":"2011","unstructured":"Malik FI, Hartman JJ, Elias KA, Morgan BP, Rodriguez H, Brejc K, et al. Cardiac myosin activation: a potential therapeutic approach for systolic heart failure. Science. 2011 Mar 18;331(6023):1439\u201343.","journal-title":"Science"},{"issue":"1","key":"831_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0002-9343(02)01472-9","volume":"114","author":"E Umana","year":"2003","unstructured":"Umana E, Solares CA, Alpert MA. Tachycardia-induced cardiomyopathy. Am J Med. 2003 Jan;114(1):51\u20135.","journal-title":"Am J Med"},{"issue":"1","key":"831_CR18","first-page":"128","volume":"11","author":"M Arsenault","year":"2002","unstructured":"Arsenault M, Plante E, Drolet MC, Couet J. Experimental aortic regurgitation in rats under echocardiographic guidance. J Heart Valve Dis. 2002 Jan;11(1):128\u201334.","journal-title":"J Heart Valve Dis."},{"issue":"7","key":"831_CR19","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0894-7317(03)00335-3","volume":"16","author":"WA Zoghbi","year":"2003","unstructured":"Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003 Jul;16(7):777\u2013802.","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"831_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1161\/01.CIR.56.2.146","volume":"56","author":"RP Lewis","year":"1977","unstructured":"Lewis RP, Rittogers SE, Froester WF, Boudoulas H. A critical review of the systolic time intervals. Circulation. 1977 Aug;56(2):146\u201358.","journal-title":"Circulation"},{"issue":"11","key":"831_CR21","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/0002-9149(84)90599-X","volume":"53","author":"DH Spodick","year":"1984","unstructured":"Spodick DH, Doi YL, Bishop RL, Hashimoto T. Systolic time intervals reconsidered. Reevaluation of the preejection period: absence of relation to heart rate. Am J Cardiol. 1984 Jun 1;53(11):1667\u201370.","journal-title":"Am J Cardiol"},{"issue":"4","key":"831_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1161\/01.CIR.0000078349.43742.8A","volume":"108","author":"LW Stevenson","year":"2003","unstructured":"Stevenson LW. Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy. Circulation. 2003 Jul 29;108(4):492\u20137.","journal-title":"Circulation"},{"issue":"1 Pt 2","key":"831_CR23","first-page":"H146","volume":"247","author":"T Wisenbaugh","year":"1984","unstructured":"Wisenbaugh T, Allen P, Cooper G 4th, O'Connor WN, Mezaros L, Streter F, Bahinski A, Houser S, Spann JF. Hypertrophy without contractile dysfunction after reversal of pressure overload in the cat. Am J Phys. 1984 Jul;247(1 Pt 2):H146\u201354.","journal-title":"Am J Phys"},{"issue":"1","key":"831_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1161\/CIRCULATIONAHA.104.488825","volume":"112","author":"R Bekeredjian","year":"2005","unstructured":"Bekeredjian R, Grayburn PA. Valvular heart disease: aortic regurgitation. Circulation. 2005 Jul 5;112(1):125\u201334.","journal-title":"Circulation"},{"key":"831_CR25","doi-asserted-by":"crossref","unstructured":"Boudoulas H. Systolic time intervals. Eur Heart J. 1990 Dec;11 Suppl I:93\u2013104.","DOI":"10.1093\/eurheartj\/11.suppl_I.93"},{"issue":"10062","key":"831_CR26","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1016\/S0140-6736(16)32049-9","volume":"388","author":"JR Teerlink","year":"2016","unstructured":"Teerlink JR, Felker GM, McMurray JJ, Solomon SD, Adams KF Jr, Cleland JG, Ezekowitz JA, Goudev A, Macdonald P, Metra M, Mitrovic V, Ponikowski P, Serpytis P, Spinar J, Tomcs\u00e1nyi J, Vandekerckhove HJ, Voors AA, Monsalvo ML, Johnston J, Malik FI. Honarpour N; COSMIC-HF investigators. Chronic oral study of myosin activation to increase contractility in heart failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial. Lancet. 2016 Dec 10;388(10062):2895\u2013903.","journal-title":"Lancet"},{"key":"831_CR27","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1161\/01.RES.12.6.611","volume":"12","author":"AG Wallace","year":"1963","unstructured":"Wallace AG, Mitchell JH, Skinner NS, Sarnoff SJ. Duration of the phases of left ventricular systole. Circ Res. 1963 Jun;12:611\u20139.","journal-title":"Circ Res"},{"issue":"1","key":"831_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jchf.2014.07.009","volume":"3","author":"BH Greenberg","year":"2015","unstructured":"Greenberg BH, Chou W, Saikali KG, Escand\u00f3n R, Lee JH, Chen MM, Treshkur T, Megreladze I, Wasserman SM, Eisenberg P, Malik FI, Wolff AA, Shaburishvili T. Safety and tolerability of omecamtiv mecarbil during exercise in patients with ischemic cardiomyopathy and angina. JACC Heart Fail. 2015 Jan;3(1):22\u20139.","journal-title":"JACC Heart Fail"},{"issue":"1 Suppl","key":"831_CR29","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1097\/01.CCM.0000296273.72952.39","volume":"36","author":"JW Petersen","year":"2008","unstructured":"Petersen JW, Felker GM. Inotropes in the management of acute heart failure. Crit Care Med. 2008 Jan;36(1 Suppl):S106\u201311.","journal-title":"Crit Care Med"},{"issue":"6","key":"831_CR30","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1046\/j.1540-8175.2001.00491.x","volume":"18","author":"N Espinola-Zavaleta","year":"2001","unstructured":"Espinola-Zavaleta N, G\u00f3mez-N\u00fa\u00f1ez N, Ch\u00e1vez PY, Sahagun-S\u00e1nchez G, Keirns C, Casanova JM, Romero-C\u00e1rdenas A, Rold\u00e1n FJ, Vargas-Barr\u00f3n J. Evaluation of the response to pharmacological stress in chronic aortic regurgitation. Echocardiography. 2001 Aug;18(6):491\u20136.","journal-title":"Echocardiography"},{"issue":"5","key":"831_CR31","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1097\/00000542-199505000-00005","volume":"82","author":"J Lev\u00e4nen","year":"1995","unstructured":"Lev\u00e4nen J, M\u00e4kel\u00e4 ML, Scheinin H. Dexmedetomidine premedication attenuates ketamine-induced cardio-stimulatory effects and post-anesthetic delirium. Anesthesiology. 1995 May;82(5):1117\u201325.","journal-title":"Anesthesiology"},{"issue":"1","key":"831_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00540-016-2278-y","volume":"31","author":"K Lee","year":"2017","unstructured":"Lee K, Hwang HJ, Kim OS, Oh YJ. Assessment of dexmedetomidine effects on left ventricular function using pressure-volume loops in rats. J Anesth. 2017 Feb;31(1):18\u201324.","journal-title":"J Anesth"},{"issue":"6 Pt 2","key":"831_CR33","first-page":"H2219","volume":"275","author":"K Asai","year":"1998","unstructured":"Asai K, Uechi M, Sato N, Shen W, Meguro T, Mathier MA, Shannon RP, Vatner SF. Lack of desensitization and enhanced efficiency of calcium channel promoter in conscious dogs with heart failure. Am J Phys. 1998 Dec;275(6 Pt 2):H2219\u201326.","journal-title":"Am J Phys"},{"issue":"1","key":"831_CR34","doi-asserted-by":"publisher","first-page":"H238","DOI":"10.1152\/ajpheart.01181.2007","volume":"294","author":"PN Banfor","year":"2008","unstructured":"Banfor PN, Preusser LC, Campbell TJ, Marsh KC, Polakowski JS, Reinhart GA, Cox BF, Fryer RM. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs. Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H238\u201348.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"831_CR35","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/j.cardfail.2006.06.292","volume":"12","author":"RL Anderson","year":"2006","unstructured":"Anderson RL, Sueoka SH, Lee KH, Rodriguez HM, Kawas RF, Godinez G, Morgan BP, Sakowicz R, Morgans DJ, Malik F, Elias KA. In vitro and in vivo characterization of CK-1827452, a selective cardiac myosin activator. J Card Fail. 2006;12:S86.","journal-title":"J Card Fail"},{"issue":"9792","key":"831_CR36","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(11)61219-1","volume":"378","author":"JR Teerlink","year":"2011","unstructured":"Teerlink JR, Clarke CP, Saikali KG, Lee JH, Chen MM, Escandon RD, Elliott L, Bee R, Habibzadeh MR, Goldman JH, Schiller NB, Malik FI, Wolff AA. Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study. Lancet. 2011 Aug 20;378(9792):667\u201375.","journal-title":"Lancet"},{"issue":"12","key":"831_CR37","doi-asserted-by":"publisher","first-page":"29060","DOI":"10.3390\/ijms161226147","volume":"16","author":"S Tariq","year":"2015","unstructured":"Tariq S, Aronow WS. Use of inotropic agents in treatment of systolic heart failure. Int J Mol Sci. 2015 Dec 4;16(12):29060\u20138.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"831_CR38","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/0002-8703(94)90129-5","volume":"127","author":"S Kojima","year":"1994","unstructured":"Kojima S, Wu ST, Parmley WW, Wikman-Coffelt J. Relationship between intracellular calcium and oxygen consumption: effects of perfusion pressure, extracellular calcium, dobutamine, and nifedipine. Am Heart J. 1994 Feb;127(2):386\u201391.","journal-title":"Am Heart J"},{"issue":"7","key":"831_CR39","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0022-2828(86)80941-5","volume":"18","author":"RW Tsien","year":"1986","unstructured":"Tsien RW, Bean BP, Hess P, Lansman JB, Nilius B, Nowycky MC. Mechanisms of calcium channel modulation by beta-adrenergic agents and dihydropyridine calcium agonists. J Mol Cell Cardiol. 1986 Jul;18(7):691\u2013710.","journal-title":"J Mol Cell Cardiol"},{"issue":"20","key":"831_CR40","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1161\/01.CIR.98.20.2141","volume":"98","author":"G Hasenfuss","year":"1998","unstructured":"\\Hasenfuss G, Pieske B, Castell M, Kretschmann B, Maier LS, Just H. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation. 1998 Nov 17;98(20):2141\u20137.","journal-title":"Circulation"},{"issue":"10","key":"831_CR41","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11886-016-0778-x","volume":"18","author":"DS Moin","year":"2016","unstructured":"Moin DS, Sackheim J, Hamo CE, Butler J. Cardiac Myosin Activators in Systolic Heart Failure: More Friend than Foe? Curr Cardiol Rep. 2016 Oct;18(10):100.","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"831_CR42","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1161\/CIRCHEARTFAILURE.114.002152","volume":"8","author":"JP Bakkehaug","year":"2015","unstructured":"Bakkehaug JP, Kildal AB, Engstad ET, Boardman N, N\u00e6sheim T, R\u00f8nning L, Aasum E, Larsen TS, Myrmel T, How OJ. Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Resting Myosin ATPase Activity. Circ Heart Fail. 2015 Jul;8(4):766\u201375.","journal-title":"Circ Heart Fail"},{"issue":"6","key":"831_CR43","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1161\/CIRCHEARTFAILURE.115.002492","volume":"8","author":"JR Teerlink","year":"2015","unstructured":"Teerlink JR, Malik FI, Kass DA. Letter by Teerlink et al regarding article, \"myosin activator Omecamtiv Mecarbil increases myocardial oxygen consumption and impairs cardiac efficiency mediated by resting myosin ATPase activity\". Circ Heart Fail. 2015 Nov;8(6):1141.","journal-title":"Circ Heart Fail"},{"key":"831_CR44","unstructured":"Anderson RL, Sueoka SH, Rodriguez HM, Lee KH, Cox DR, Kawas R, Morgan BP, Sakowicz R, Morgans DJ, Malik F, Elias KA. In vitro and in vivo efficacy of the cardiac myosin activator CK-1827452. Mol bio cell. 2005;16(abstract #1728). \n                    https:\/\/cytokinetics.com\/wp-content\/uploads\/2015\/10\/ASCB_1728.pdf\n                    \n                  ."},{"issue":"9792","key":"831_CR45","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/S0140-6736(11)61126-4","volume":"378","author":"JG Cleland","year":"2011","unstructured":"Cleland JG, Teerlink JR, Senior R, Nifontov EM, Mc Murray JJ, Lang CC, et al. The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. Lancet. 2011 Aug 20;378(9792):676\u201383.","journal-title":"Lancet"},{"issue":"12","key":"831_CR46","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.jacc.2016.01.031","volume":"67","author":"JR Teerlink","year":"2016","unstructured":"Teerlink JR, Felker GM, McMurray JJ, Ponikowski P, Metra M, Filippatos GS. ATOMIC-AHF investigators. Acute treatment with Omecamtiv Mecarbil to increase contractility in acute heart failure: the ATOMIC-AHF study. J Am Coll Cardiol. 2016 Mar 29;67(12):1444\u201355.","journal-title":"J Am Coll Cardiol"},{"key":"831_CR47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejphar.2017.05.027","volume":"809","author":"P N\u00e1n\u00e1si Jr","year":"2017","unstructured":"N\u00e1n\u00e1si P Jr, Gaburjakova M, Gaburjakova J, Alm\u00e1ssy J. Omecamtiv mecarbil activates ryanodine receptors from canine cardiac but not skeletal muscle. Eur J Pharmacol. 2017 Aug 15;809:73\u20139.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"831_CR48","first-page":"281","volume":"16","author":"J Dervan","year":"1986","unstructured":"Dervan J, Goldberg S. Acute aortic regurgitation: pathophysiology and management. Cardiovasc Clin. 1986;16(2):281\u20138.","journal-title":"Cardiovasc Clin"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0831-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-018-0831-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0831-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T19:07:59Z","timestamp":1558379279000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-018-0831-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,21]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["831"],"URL":"https:\/\/doi.org\/10.1186\/s12872-018-0831-3","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,21]]},"assertion":[{"value":"9 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Experiments were approved by the Institutional Animal Care and Use Committee of the Free University of Brussels under N\u00b0 461\u00a0N. Studies were conducted at the Laboratory of Physiology of the University of Brussels (LA 1230334) in accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH Publication No. 85\u201323, revised 1996).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"99"}}